Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
GenFleet Therapeutics to Present Phase I Data for GFH312 at 2023 American Society for Clinical Pharmacology & Therapeutics Meeting 2023-03-09 19:00
World-First, 45,000 patients study to develop AI-based "precision medicine" for migraine relief - collaboration between Healint and University of Geneva, Switzerland 2023-03-09 16:55
Estrella Biopharma Announces FDA Clearance of IND Application for Phase I/II Clinical Trial (Starlight-1) of EB103, a CD19-Targeted ARTEMIS® T Cell Therapy, to Patients with B-Cell Lymphomas 2023-03-09 05:15
Decipher Fat Burning: A Breath Analyzer Achieved Funding Goal on Indiegogo in 1 Hour 2023-03-09 00:00
BIORCHESTRA Participating in Two Upcoming Therapeutic RNA-Focused Events 2023-03-08 22:47
Hovione receives the 2023 CDMO Leadership Award in all six categories and is Champion in Compatibility and Expertise 2023-03-08 22:00
The Next Generation of Smart home gym: Kickstarter Success - HooKee, to launch the Indiegogo Campaign 2023-03-07 21:20
MSCI ESG Updated I-Mab to "A" Rating 2023-03-07 21:02
AnPac Bio Announces Receipt of the First Payment from a Malaysia Customer On a Signed US$1.5 Million Cancer Detection Equipment Purchase Contract 2023-03-07 20:30
SiYi Intelligence Raises Nearly $15 Million in Series A Financing 2023-03-06 22:05
AnPac Bio-Medical Science Announces US$5 Million Private Placement 2023-03-06 21:30
HanAll Biopharma's Licensed Partner in China Announces Positive Topline Phase 3 Results for Batoclimab in Myasthenia Gravis 2023-03-06 20:00
Assure Tech Launches a New Platform - Comprehensive Health Solution 2023-03-06 18:47
Harbour BioMed Announces Positive Topline Results from Phase III Trial of Batoclimab for Treatment of Generalized Myasthenia Gravis 2023-03-06 14:27
US proteomics sector set for shake-up as new IonOpticks tech unveiled 2023-03-03 22:00
Neurophet to unveil new technology for analyzing ARIA side effect at ECR 2023 2023-03-02 22:00
Porton Advanced Collaborates with DanausGT to Accelerate the Development of Gene and Cell Therapy 2023-03-02 20:00
Sanyou Biopharmaceuticals opens Cambridge MA, US office, expanding its business outreach to a central hub of biotech network 2023-03-02 18:00
111 to Announce Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results- Conference Call to Follow 2023-03-02 15:35
ExoCoBio obtained 2 GMP Licenses for Exosome Biopharmaceuticals from Korea MFDS and for Hyaluronic Acid (HA) Dermal Fillers from Brazil ANVISA 2023-03-02 14:09
1 100 101 102 103 104 801